FSRH response MHRA consultation Hana as Pharmacy medicine March 2021

1af941c4abcb21c6747cb9dc7c8f98b5

Published on: 4 March 2021

File size: 605kb PDF

File type: FSRH Consultation Response

We respond to the consultation by The Medicines and Healthcare Products Regulatory Agency (MHRA) on whether to reclassify Hana, a progestogen-only contraceptive pill, as Pharmacy (P) medicine.

Your download should start automatically. If not download directly.